Back to today’s briefing

Story perspectives

FDA Approves Drug for Autism; Parents Seek Answers

10/8/2025

50 9

Summary

Story summary

The Food and Drug Administration (FDA) approved leucovorin calcium tablets for cerebral folate deficiency on September 22, signaling potential autism benefits.
After the announcement, many parents of autistic children joined a Facebook group to discuss the drug.
Some parents reported doctors refusing to prescribe leucovorin. Discussions circulated unverified alternatives and conspiracy theories blaming big pharma and vaccines.

1 of 1

Story summary

The Food and Drug Administration (FDA) approved leucovorin calcium tablets for cerebral folate deficiency on September 22, signaling potential autism benefits.
After the announcement, many parents of autistic children joined a Facebook group to discuss the drug.
Some parents reported doctors refusing to prescribe leucovorin. Discussions circulated unverified alternatives and conspiracy theories blaming big pharma and vaccines.